HPTN 039
A Phase III, randomized, double-blind, placebo-controlled trial of acyclovir for the reduction of HIV acquisition among high risk HSV-2 seropositive, HIV-seronegative individuals
Meetings and Presentations
- HPTN 039 WSM Retreat (May 18-19, 2007)
- HPTN Annual Meeting 039 Session
- Africa Team: Zimbabwe-Zambia-South Africa Training & Implementation Summit #2
HPTN 039 WSM Retreat (May 18-19, 2007)
Download Retreat notebook documents (zip file)
-
Investigators' Update on Clinical Research
-
Overview of Progress of HPTN 039 - Connie Celum
-
Shedding Study - Sinead Delany-Moretlwe
-
Mwanza Trial - Debbie Watson-Jones
-
-
Product Extension - Sam Griffith
-
Breakout Sessions
-
Medication Adherence Sub-study in Zimbabwe - Euphemia Sibanda
-
Impacta's Successful Strategies for Retention and QA: Database Demonstration - Jesus Peinaeo
-
Media Training
-
Site Presentations: What Worked and What Did Not Work in HPTN 039
HPTN Annual Meeting 039 Session, February 22, 2006
Africa Team: Zimbabwe-Zambia-South Africa Training & Implementation Summit #2, January 20-22, 2006
-
Full Summit Report (PDF) (large file; some users may experience long download times)
Individual Report Sections
-
Data and Statistical Presentation
-
039 Site Background Overviews
-
Site Action Plan update from 2005
-
2006 Action Plans per Site
-
Update on Challenges: Working Groups 2005
-
Challenge/Cause/Solution Charts 2006 for Working Groups